FDA-Approved device for dialysis access under Long-Term review
NCT ID NCT07146854
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 26 times
Summary
This study follows 150 adults with end-stage kidney disease who need a graft for hemodialysis. The EndoForce System, already approved by the FDA, connects the graft to a vein. Researchers will track safety and how well the graft works over time, including any complications or need for additional procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MUSC Health Orangeburg
NOT_YET_RECRUITINGOrangeburg, South Carolina, 29118, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Spartanburg Regional Medical Center
RECRUITINGSpartanburg, South Carolina, 29303, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.